About: Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020 Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована у вересні 2006 (uk) artículu científicu espublizáu en setiembre de 2006 (ast) scientific article published on 01 September 2006 (en)
publication date	wds:Q80193015-711F7149-24EC-4FFE-B427-D8312ACDE93C
publication date	2006-09-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q80193015-07AE07C8-3D64-4352-89B4-FD64CD4FBEB9 wds:Q80193015-1E5CE362-8A58-49F0-AC63-4CA582922A9C wds:Q80193015-1EC80AC9-6F36-46AC-ACC8-CC61E7D1DACF wds:Q80193015-1FB49FAC-70E2-47B4-B028-5E7DABDF685C wds:Q80193015-475F50C9-8E18-4BFE-A35E-F787996D3D85 wds:Q80193015-567F37D4-8A91-4E22-96B4-FA6E1C316C14 wds:Q80193015-5EF72A11-FF5E-42AA-9EB7-46267A882B0A wds:Q80193015-68F6A58A-28F1-45DD-9A2D-2A0637CE1A50 wds:Q80193015-6AD4BA71-8177-4930-AF8B-261308C8C301 wds:Q80193015-6D433771-5931-461B-9D90-ADCA87C0F33C wds:Q80193015-80933FD2-7714-44E5-8AA4-F8626B09B376 wds:Q80193015-8AAC922B-F731-40A2-A2EF-B5DAB605C157 wds:Q80193015-92B8801C-8A27-4607-B1AA-36E334A9F083 wds:Q80193015-9BDEFF41-C6A2-4448-98C1-EC5FDF1387E2 wds:Q80193015-ACA0376F-2F0B-4802-9313-350CECEECC91 wds:Q80193015-C8935ED5-A318-4D01-9BDF-211A26795CD7 wds:Q80193015-CDF34947-2052-4DA3-B39E-9DF7AAB686E6 wds:Q80193015-EA497C9B-412F-4040-9CD8-91FC0A7CDF59
author name string	John M Kane Jeffrey E Lee James E Herndon Merrick I Ross Douglas S Tyler R Dirk Noyes Richard L White Linda M McCall Paul F Mansfield Wendy R Cornett David J Winchester James F Pingpank Jeffrey J Sussman William G Kraybill Rebecca P Petersen Vijaya Chadaram Henry A Briele American College of Surgeons Oncology Group Trial Z0020
rdfs:label	Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020 (en) Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020 (nl)
skos:prefLabel	Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020 (en) Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020 (nl)
name	Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020 (en) Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020 (nl)
author	wds:Q80193015-86497CBA-1D10-48EC-9E0D-F88DE92FCA04 wds:Q80193015-F15FF271-D375-489E-9C36-061C6A6B0B0A
author	H. Richard Alexander Douglas L. Fraker
title	wds:Q80193015-83D4AA93-693A-46D7-B95B-BEC2B6536378
title	Randomized multicenter trial of hyperthermic isolated limb perfusion with melphalan alone compared with melphalan plus tumor necrosis factor: American College of Surgeons Oncology Group Trial Z0020 (en)
page(s)	wds:Q80193015-33EEB3D9-E5F9-4A48-93BD-6C4F0EA07CAB
page(s)	4196-4201
instance of	wds:Q80193015-09DFB76E-8839-4DE3-B8A5-916070556FC6
instance of	scholarly article
main subject	wds:Q80193015-FA657235-8134-4B8E-B728-EC8920B47F2E
main subject	multicenter clinical trial
PubMed ID	wds:Q80193015-AA179566-0B57-4148-8378-59C8523A0589
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/16943537
PubMed ID	16943537
published in	wds:Q80193015-4678008F-C5F1-4184-A8A2-A49DE3312368
published in	Journal of Clinical Oncology
issue	wds:Q80193015-026D6ED2-D1CD-4BB6-8B64-C33F37AE2A61
volume	wds:Q80193015-6DA249DA-613C-4791-B5D6-8D0658739588
issue	25
volume	24
DOI	wds:Q80193015-437F7B21-CB2D-4BCB-B2A4-C9041104FF80
DOI	http://dx.doi.org/10.1200/JCO.2005.05.5152
DOI	10.1200/JCO.2005.05.5152
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q80193015
is cites work of	Tumor necrosis factor and cancer, buddies or foes? Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy Treatment of cutaneous melanoma: current approaches and future prospects. Isolated limb perfusion for malignant melanoma: systematic review on effectiveness and safety Regional chemotherapy in locally advanced pancreatic cancer: RECLAP trial A phase 1 study of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with locally advanced in-transit malignant melanoma. Prospective multicenter phase II trial of systemic ADH-1 in combination with melphalan via isolated limb infusion in patients with advanced extremity melanoma Surgical immune interventions for solid malignancies 20 years experience of TNF-based isolated limb perfusion for in-transit melanoma metastases: TNF dose matters Optimizing regional infusion treatment strategies for melanoma of the extremities Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity. Current position of TNF-α in melanomagenesis The Role of Regional Therapies for in-Transit Melanoma in the Era of Improved Systemic Options Analysis of factors influencing outcome in patients with in-transit malignant melanoma undergoing isolated limb perfusion using modern treatment parameters Intra-arterial perfusion-based therapies for regionally metastatic cutaneous and uveal melanoma Regional treatment strategies for in-transit melanoma metastasis Minimally invasive intra-arterial regional therapy for metastatic melanoma: isolated limb infusion and percutaneous hepatic perfusion Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion Limb preservation with isolated limb infusion for locally advanced nonmelanoma cutaneous and soft-tissue malignant neoplasms Oncodriver inhibition and CD4+ Th1 cytokines cooperate through Stat1 activation to induce tumor senescence and apoptosis in HER2+ and triple negative breast cancer: implications for combining immune and targeted therapies. Regional therapies for locoregionally advanced and unresectable melanoma Study and treatment of locally advanced melanoma Current treatment of locoregional recurrence of melanoma A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software